Literature DB >> 28654216

Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR.

M D Parkes1, P F Halloran1,2, L G Hidalgo1,3.   

Abstract

Human organ allograft rejection depends on effector lymphocytes: NK cells in antibody-mediated rejection (ABMR) and effector T cells in T cell-mediated rejection (TCMR). We hypothesized that NK cell CD16a stimulation and CD8 T cell TCR/CD3 stimulation represent highly similar effector systems, and should lead to shared molecular changes between ABMR and TCMR. We studied similarity between soluble proteins and the transcripts induced in CD16a stimulated NK cells and TCR/CD3-stimulated T cells in vitro. Of 30 soluble mediators tested, CD16a-activated NK cells and CD3/TCR activated T cells produced the same limited set of five mediators-CCL3, CCL4, CSF2, IFNG, and TNF-and failed to produce 25 others. Many transcripts increased in stimulated NK cells were also increased in CD3-stimulated CD8 T cells (FDR < 0.05), including IFNG, CSF2, CCL3, CCL4, and XCL1. We hypothesized that shared transcripts not produced by other cell types should be expressed both in ABMR and TCMR kidney transplant biopsies. CD160, XCL1, TNFRSF9, and IFNG were selective for TCR/CD3-activated T cells and CD16a-NK cells and all were strongly increased in ABMR and TCMR. The molecules such as CD160 and XCL1 shared between NK cells in ABMR and effector T cells in TCMR may hold insights into important rejection mechanisms.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; basic (laboratory) research/science; kidney transplantation/nephrology; microarray/gene array; natural killer (NK) cells/NK receptors; rejection; rejection: antibody-mediated (ABMR)

Mesh:

Substances:

Year:  2017        PMID: 28654216     DOI: 10.1111/ajt.14410

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

Review 1.  Recent advances in CD8+ regulatory T cell research.

Authors:  Yating Yu; Xinbo Ma; Rufei Gong; Jianmeng Zhu; Lihua Wei; Jinguang Yao
Journal:  Oncol Lett       Date:  2018-03-29       Impact factor: 2.967

2.  Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Authors:  Weijia Zhang; Zhengzi Yi; Chengguo Wei; Karen L Keung; Zeguo Sun; Caixia Xi; Christopher Woytovich; Samira Farouk; Lorenzo Gallon; Madhav C Menon; Ciara Magee; Nader Najafian; Milagros D Samaniego; Arjang Djamali; Stephen I Alexander; Ivy A Rosales; Rex Neal Smith; Philip J O'Connell; Robert Colvin; Paolo Cravedi; Barbara Murphy
Journal:  JCI Insight       Date:  2019-06-06

3.  The synergism of B and T lymphocyte attenuator (BTLA) and cytotoxic T lymphocyte associated antigen-4 (CTLA-4) attenuated acute T-cell mediated rejection and prolonged renal graft survival.

Authors:  Hengcheng Zhang; Zijie Wang; Jiayi Zhang; Xiang Zhang; Zeping Gui; Li Sun; Haiwei Yang; Ruoyun Tan; Min Gu
Journal:  Transl Androl Urol       Date:  2020-10

4.  Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.

Authors:  Katelynn S Madill-Thomsen; Georg A Böhmig; Jonathan Bromberg; Gunilla Einecke; Farsad Eskandary; Gaurav Gupta; Luis G Hidalgo; Marek Myslak; Ondrej Viklicky; Agnieszka Perkowska-Ptasinska; Philip F Halloran
Journal:  J Am Soc Nephrol       Date:  2021-07-12       Impact factor: 10.121

5.  B-cell Deficiency Attenuates Transplant Glomerulopathy in a Rat Model of Chronic Active Antibody-mediated Rejection.

Authors:  Shannon R Reese; Nancy A Wilson; Yabing Huang; Lucille Ptak; Kenna R Degner; Ding Xiang; Robert R Redfield; Weixiong Zhong; Sarah E Panzer
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

6.  LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue.

Authors:  Linpei Jia; Rufu Jia; Yinping Li; Xiaoxia Li; Qiang Jia; Hongliang Zhang
Journal:  J Immunol Res       Date:  2018-06-07       Impact factor: 4.818

7.  Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients.

Authors:  Beatriz Díaz-Molina; Paula Diaz-Bulnes; Reyes Carvajal Palao; Maria José Bernardo; Ramón M Rodriguez; Viviana Corte-Iglesias; Cesar Moris de la Tassa; Jose Luis Lambert; Beatriz Suarez-Alvarez
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

8.  Natural Killer Cells Promote Kidney Graft Rejection Independently of Cyclosporine A Therapy.

Authors:  Muhammad Imtiaz Ashraf; Attia Sarwar; Anja A Kühl; Elena Hunger; Arne Sattler; Felix Aigner; Heinz Regele; Martina Sauter; Karin Klingel; Stefan Schneeberger; Thomas Resch; Katja Kotsch
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

9.  CD56+CD57+ infiltrates as the most predominant subset of intragraft natural killer cells in renal transplant biopsies with antibody-mediated rejection.

Authors:  Hey Rim Jung; Mi Joung Kim; Yu-Mee Wee; Jee Yeon Kim; Monica Young Choi; Ji Yoon Choi; Hyunwook Kwon; Joo Hee Jung; Yong Mee Cho; Heounjeong Go; Sang-Yeob Kim; Yeon-Mi Ryu; Yun Jae Kim; Young Hoon Kim; Duck Jong Han; Sung Shin
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

Review 10.  The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation.

Authors:  Paola Pontrelli; Federica Rascio; Giuseppe Castellano; Giuseppe Grandaliano; Loreto Gesualdo; Giovanni Stallone
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.